(Q46378094)

English

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

chronic renal disease

1 reference

based on heuristic

inferred from title

Carmine Zoccali

17

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Giuseppe Remuzzi

18

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Bogdan Ene-Iordache

object named as

Bogdan Ene-Iordache

5

0 references

Piero Ruggenenti

1

object named as

Piero Ruggenenti

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

2

object named as

Annalisa Perna

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Maria G. Ganeva

4

object named as

Maria Ganeva

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Giacomina Loriga

3

object named as

Giacomina Loriga

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Daniela Leonardis

10

object named as

Daniela Leonardis

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

REIN-2 Study Group

19

object named as

REIN-2 Study Group

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Elena Perticucci

8

object named as

Elena Perticucci

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

6

object named as

Marta Turturro

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

7

object named as

Maria Lesti

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

14

object named as

Mirella Alpa

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

author name string

Ivan Nediyalkov Chakarski

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Giovanni Garini

11

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Adalberto Sessa

12

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Carlo Basile

13

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Renzo Scanziani

15

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Gianbattista Sorba

16

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

365

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

9463

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

939-946

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Hypertension and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomisation methods in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated assessment of results in clinical trials of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors versus calcium antagonists in the progression of renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nifedipine versus fosinopril in uninephrectomized diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of calcium antagonists in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2971082-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)71082-5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15766995

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46378094&oldid=2108707942"